![{[setting('site_name')]}](https://projxnews.com/uploads/setting/16983847711140531930.webp)
Liha Life Science Private Limited is embarking on a transformative journey with its Bulk Drugs & Intermediate Unit Project in Kadechur, Kalaburagi, Karnataka. This pioneering venture signifies a significant investment of 25 crores and aims to establish the company as a key player in the production of bulk drugs and intermediates. With a projected capacity of 50 tons per month, the facility is poised to cater to the growing demand for pharmaceutical ingredients both domestically and internationally.
Situated in the industrial zone of Kadechur, Kalaburagi, Karnataka, the project benefits from strategic proximity to raw material sources and transportation networks. This favorable location enhances operational efficiency and facilitates seamless distribution, positioning Liha Life Science Private Limited as a reliable supplier of bulk drugs and intermediates in the region.
The Bulk Drugs & Intermediate Unit Project reflects the company's commitment to innovation, quality, and sustainability. By leveraging advanced manufacturing processes and adhering to stringent quality standards, Liha Life Science Private Limited aims to deliver high-quality pharmaceutical ingredients that meet the stringent requirements of its diverse clientele.
News by Rahul Yelligetti
